Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 11
Submit an article Journal homepage
237
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Philadelphia chromosome-positive acute lymphoblastic leukemia in China: a retrospective study from the Chinese Childhood Cancer Group

Yi-Jin GaoDepartment of Pediatric Hematology and Oncology, Key Laboratory of Pediatric Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Ye GuoKey Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital and Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China;
,
Shao-Yan HuDepartment of Hematology and Oncology, Children’s Hospital of Soochow University, Suzhou, Jiangsu, China;
,
Yi-Ping ZhuDepartment of Pediatric Hematology and Oncology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, China;
,
Qun HuDepartment of Pediatric Hematology and Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China;
,
Jie YuDepartment of Hematology, Key Laboratory of Childhood Development and Disorders, Chongqing Children’s Hospital, Chongqing Medical University, Chongqing, China
,
Hai-Long HeDepartment of Hematology and Oncology, Children’s Hospital of Soochow University, Suzhou, Jiangsu, China;
,
Yuan AiDepartment of Pediatric Hematology and Oncology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, China;
,
Ai ZhangDepartment of Pediatric Hematology and Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China;
,
Ying XianDepartment of Hematology, Key Laboratory of Childhood Development and Disorders, Chongqing Children’s Hospital, Chongqing Medical University, Chongqing, China
,
Jing ChenDepartment of Pediatric Hematology and Oncology, Key Laboratory of Pediatric Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
&
Xiao-Fan ZhuKey Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital and Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Correspondence[email protected]
 show all
Pages 2696-2698 | Received 17 Sep 2015, Accepted 15 Feb 2016, Published online: 19 May 2016

References

  • Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83–103.
  • Aricò M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 2000;342:998–1006.
  • Aricò M, Schrappe M, Hunger SP, et al. Clinical outcome of children with newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol. 2010;28:4755–4761.
  • Schultz KR, Bowman WP, Aledo A, et al. Improved early event-free survival with imatinib in philadelphia chromosome-positive acute lymphoblastic leukemia: a children’s oncology group study. J Clin Oncol. 2009;27:5175–5181.
  • Schultz KR, Carroll A, Heerema NA, et al. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: children’s oncology group study AALL0031. Leukemia. 2014;28:1467–1471.
  • Rives S, Estella J, Gómez P, et al. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish cooperative group SHOP studies ALL-94, ALL-99 and ALL. Br J Haematol. 2011;154:600–2005. 11.
  • Biondi A, Schrappe M, De Lorenzo P, et al. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome positive acute lymphoblastic leukemia (EsPhALL): a randomized, open-label, intergroup study. Lancet Oncol. 2012;13:936–945.
  • Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol. 2011;12:719–720.
  • Luo XQ, Ke ZY, Huang LB, et al. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome. Pediatr Blood Cancer. 2009;52:191–195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.